KEY TAKEAWAY: Few cancer drugs approved via the accelerated FDA approval pathway were judged to have verified benefits based on improvement in survival reported in confirmatory trials.
Tag: Cancer drugs
Pharma ignores patients as new cancer drug data are released
62 percent of cancer patients report being in debt due to their treatment. 55 percent accrue at least $10,000 in debt, while 3 percent file for bankruptcy. Cancer costs exceed…
No amount of innovation can justify the doubling of prices for cancer drugs
POST SUMMARY: The number of over-65s on the planet is projected almost to triple between 2010 and 2050 to 1.5bn, according to the UN. This, in turn, will spur a surge…
Cost vs. benefit of cancer drugs
“Is a $30,000-a-month drug that improves survival by 1.4 months effective? At the ASCO meeting this week, that dialog has already begun. In a forum on drug costs, Dr. Ezekiel…
Extending the lives of cancer patients, but at what cost ?
The Food and Drug Administration on Friday approved Celgene’s drug Abraxane for use in treating advanced pancreatic cancer which in clinical trials prolonged the lives of patients by a little less…